Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 13
2003 14
2004 8
2005 14
2006 13
2007 10
2008 7
2009 13
2010 9
2011 19
2012 11
2013 10
2014 10
2015 12
2016 14
2017 20
2018 23
2019 22
2020 19
Text availability
Article attribute
Article type
Publication date

Search Results

238 results
Results by year
Filters applied: . Clear all
Page 1
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.
Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, Ishida T, Sekino H, Yamada K, Portsmouth S, Kawaguchi K, Shishido T, Arai M, Tsuchiya K, Uehara T, Watanabe A; Baloxavir Marboxil Investigators Group. Hayden FG, et al. N Engl J Med. 2018 Sep 6;379(10):913-923. doi: 10.1056/NEJMoa1716197. N Engl J Med. 2018. PMID: 30184455 Free article. Clinical Trial.
Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge.
Koyasu S, Kobayashi M, Goto Y, Hiraoka M, Harada H. Koyasu S, et al. Among authors: harada h. Cancer Sci. 2018 Mar;109(3):560-571. doi: 10.1111/cas.13483. Epub 2018 Jan 27. Cancer Sci. 2018. PMID: 29285833 Free PMC article. Review.
HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance.
Nagao A, Kobayashi M, Koyasu S, Chow CCT, Harada H. Nagao A, et al. Among authors: harada h. Int J Mol Sci. 2019 Jan 9;20(2):238. doi: 10.3390/ijms20020238. Int J Mol Sci. 2019. PMID: 30634433 Free PMC article. Review.
A circadian clock gene, PER2, activates HIF-1 as an effector molecule for recruitment of HIF-1α to promoter regions of its downstream genes.
Kobayashi M, Morinibu A, Koyasu S, Goto Y, Hiraoka M, Harada H. Kobayashi M, et al. Among authors: harada h. FEBS J. 2017 Nov;284(22):3804-3816. doi: 10.1111/febs.14280. Epub 2017 Oct 16. FEBS J. 2017. PMID: 28963769 Free article.
Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice.
Nakashima Y, Kondo M, Shono E, Ishinishi T, Tsukamoto H, Kuroda K, Maeyama A, Harada H, Maekawa M, Shimauchi T, Nagamine R, Jojima H, Yoshizawa S, Tsuru T, Otsuka T, Miyahara H, Suematsu E, Wada K, Yoshizawa S, Inoue Y, Fukuda T, Ikemura S, Haraguchi A. Nakashima Y, et al. Among authors: harada h. Mod Rheumatol. 2020 Sep;30(5):807-815. doi: 10.1080/14397595.2019.1676369. Epub 2019 Oct 17. Mod Rheumatol. 2020. PMID: 31580188
IL-6 blockade for myocardial infarction.
Iuchi A, Harada H, Tanaka T. Iuchi A, et al. Among authors: harada h. Int J Cardiol. 2018 Nov 15;271:19-20. doi: 10.1016/j.ijcard.2018.06.068. Epub 2018 Jun 21. Int J Cardiol. 2018. PMID: 30482454 No abstract available.
Suppression of mitochondrial oxygen metabolism mediated by the transcription factor HIF-1 alleviates propofol-induced cell toxicity.
Sumi C, Okamoto A, Tanaka H, Kusunoki M, Shoji T, Uba T, Adachi T, Iwai T, Nishi K, Harada H, Bono H, Matsuo Y, Hirota K. Sumi C, et al. Among authors: harada h. Sci Rep. 2018 Jun 12;8(1):8987. doi: 10.1038/s41598-018-27220-8. Sci Rep. 2018. PMID: 29895831 Free PMC article.
ALC1/CHD1L, a chromatin-remodeling enzyme, is required for efficient base excision repair.
Tsuda M, Cho K, Ooka M, Shimizu N, Watanabe R, Yasui A, Nakazawa Y, Ogi T, Harada H, Agama K, Nakamura J, Asada R, Fujiike H, Sakuma T, Yamamoto T, Murai J, Hiraoka M, Koike K, Pommier Y, Takeda S, Hirota K. Tsuda M, et al. Among authors: harada h. PLoS One. 2017 Nov 17;12(11):e0188320. doi: 10.1371/journal.pone.0188320. eCollection 2017. PLoS One. 2017. PMID: 29149203 Free PMC article.
Survey of thrombotic microangiopathy within 1 week after kidney transplantation between 2010 and 2015 in Japan.
Satoh S, Saito K, Harada H, Okumi M, Saito M; Survey Committee for TA-TMA of the Japan Society for Transplantation. Satoh S, et al. Among authors: harada h. Clin Exp Nephrol. 2019 Apr;23(4):571-572. doi: 10.1007/s10157-018-1655-2. Epub 2018 Dec 11. Clin Exp Nephrol. 2019. PMID: 30539337 No abstract available.
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial).
Fujisawa S, Ueda Y, Usuki K, Kobayashi H, Kondo E, Doki N, Nakao T, Kanda Y, Kosugi N, Kosugi H, Kumagai T, Harada H, Shikami M, Maeda Y, Sakura T, Inokuchi K, Saito A, Nawa Y, Ogasawara M, Nishida J, Kondo T, Yoshida C, Kuroda H, Tabe Y, Maeda Y, Imajo K, Kojima K, Morita S, Komukai S, Kawaguchi A, Sakamoto J, Kimura S. Fujisawa S, et al. Among authors: harada h. Int J Clin Oncol. 2019 Apr;24(4):445-453. doi: 10.1007/s10147-018-1368-2. Epub 2018 Nov 12. Int J Clin Oncol. 2019. PMID: 30421023 Free PMC article. Clinical Trial.
238 results
Jump to page
Feedback